WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Net Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹-55 Cr | ₹-198 Cr | ₹-189 Cr | ₹-258 Cr | ₹-217 Cr |
What is the latest Net Current Assets ratio of WANBURY ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹-55 Cr |
Mar2023 | ₹-198 Cr |
Mar2022 | ₹-189 Cr |
Mar2021 | ₹-258 Cr |
Mar2020 | ₹-217 Cr |
How is Net Current Assets of WANBURY Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹-55 Cr | Negative | |
Mar2023 | ₹-198 Cr | Negative | |
Mar2022 | ₹-189 Cr | Negative | |
Mar2021 | ₹-258 Cr | Negative | |
Mar2020 | ₹-217 Cr | - |
Compare Net Current Assets of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹872.7 Cr | -1.1% | -10.8% | -9.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹392,567.0 Cr | 0.5% | 4.6% | -18.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹151,601.0 Cr | -3.2% | -6.7% | 4.4% | Stock Analytics | |
CIPLA | ₹122,284.0 Cr | 0.3% | -3.5% | -10.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,593.0 Cr | 0.9% | -0.6% | 3.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,014.0 Cr | -2.2% | -0.9% | -9.4% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | -1.1% |
-10.8% |
-9.7% |
SENSEX | -0.9% |
0.8% |
-5.7% |
You may also like the below Video Courses